# Study of Oral Bisphosphonate for Osteopenic Women Treated With Adjuvant Aromatase Inhibitors

> **NCT02616744** · PHASE2 · COMPLETED · sponsor: **Azienda Ospedaliero-Universitaria Careggi** · enrollment: 171 (actual)

## Conditions studied

- Breast Cancer

## Interventions

- **DRUG:** Ibandronic acid
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02616744
- **Lead sponsor:** Azienda Ospedaliero-Universitaria Careggi
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-01
- **Primary completion:** 2016-05
- **Final completion:** 2016-05
- **Target enrollment:** 171 (ACTUAL)
- **Last updated:** 2019-10-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02616744

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02616744, "Study of Oral Bisphosphonate for Osteopenic Women Treated With Adjuvant Aromatase Inhibitors". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02616744. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*